HUP0204417A2 - Oral ciprofloxacin-composition of controlled release - Google Patents
Oral ciprofloxacin-composition of controlled releaseInfo
- Publication number
- HUP0204417A2 HUP0204417A2 HU0204417A HUP0204417A HUP0204417A2 HU P0204417 A2 HUP0204417 A2 HU P0204417A2 HU 0204417 A HU0204417 A HU 0204417A HU P0204417 A HUP0204417 A HU P0204417A HU P0204417 A2 HUP0204417 A2 HU P0204417A2
- Authority
- HU
- Hungary
- Prior art keywords
- controlled release
- composition
- weight
- ciprofloxacin
- oral
- Prior art date
Links
- 238000013270 controlled release Methods 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960003405 ciprofloxacin Drugs 0.000 abstract 1
- 239000003349 gelling agent Substances 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány tárgya szabályozott hatóanyag leadására szolgáló, orális,napi egyszeri humán tablettakészítmény, amely hatóanyagkéntgyógyászatilag hatásos mennyiségű ciprofloxacint, valamintsegédanyagként 0,1-8,0 tömeg% viszkózussá tevő és/vagy gélesítőanyagot, 5,0-15 tömeg% gázképző anyagot és 3,0-15 tömeg% duzzadókomponenst tartalmaz. ÓThe subject of the invention is an oral, once-a-day human tablet preparation for the controlled release of an active ingredient, which contains a medicinally effective amount of ciprofloxacin as the active ingredient, as well as 0.1-8.0% by weight of a viscous and/or gelling agent, 5.0-15% by weight of a gas-forming agent and 3, Contains 0-15% swelling component by weight. HE
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51788700A | 2000-03-03 | 2000-03-03 | |
PCT/IB2001/000279 WO2001064183A1 (en) | 2000-03-03 | 2001-02-28 | Orally administered controlled delivery system for once daily administration of ciprofloxacin |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0204417A2 true HUP0204417A2 (en) | 2003-05-28 |
HUP0204417A3 HUP0204417A3 (en) | 2005-03-29 |
Family
ID=24061635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0204417A HUP0204417A3 (en) | 2000-03-03 | 2001-02-28 | Oral ciprofloxacin-composition of controlled release |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP1263409A1 (en) |
JP (1) | JP2003525229A (en) |
KR (1) | KR20030009374A (en) |
CN (1) | CN1420763A (en) |
AP (2) | AP1485A (en) |
AR (1) | AR032614A1 (en) |
AU (1) | AU3589701A (en) |
BG (1) | BG107055A (en) |
BR (1) | BR0108958A (en) |
CA (1) | CA2400950A1 (en) |
CZ (1) | CZ20022883A3 (en) |
DO (1) | DOP2001000130A (en) |
EA (1) | EA200200914A1 (en) |
EC (1) | ECSP013952A (en) |
EE (1) | EE200200497A (en) |
GT (1) | GT200100033A (en) |
HN (1) | HN2001000038A (en) |
HR (1) | HRP20020715A2 (en) |
HU (1) | HUP0204417A3 (en) |
IL (1) | IL151553A0 (en) |
IS (1) | IS6532A (en) |
MX (1) | MXPA02008568A (en) |
NO (1) | NO20024108L (en) |
NZ (1) | NZ520927A (en) |
OA (1) | OA12381A (en) |
PE (1) | PE20011113A1 (en) |
PL (1) | PL365071A1 (en) |
SK (1) | SK12542002A3 (en) |
WO (1) | WO2001064183A1 (en) |
YU (1) | YU66202A (en) |
ZA (1) | ZA200206764B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0209265D0 (en) | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
US20030229101A1 (en) * | 2002-06-06 | 2003-12-11 | Sherman Bernard Charles | Tablets comprising ciprofloxacin hydrochloride |
DE10351448A1 (en) | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Flavor-containing drug formulations with improved pharmaceutical properties |
DE602005007205D1 (en) | 2005-07-19 | 2008-07-10 | Ethypharm Sa | Gastroretentive compositions and methods of preparation |
DE602006012962D1 (en) * | 2006-07-19 | 2010-04-29 | Tabuk Pharmaceutical Mfg Co | Pharmaceutical preparations of ciprofloxacin |
WO2016115253A1 (en) | 2015-01-14 | 2016-07-21 | The Regents Of The University Ofcolordo, A Body Corporate | Insulin mimotopes and methods of using the same |
CA3015400A1 (en) * | 2016-02-23 | 2017-08-31 | Matripharm International Inc. | Dual-rate release formulation with high drug loading |
CA3018727C (en) | 2016-03-24 | 2024-03-26 | The Regents Of The University Of Colorado, A Body Corporate | Methods of treating autoimmune disease |
US11052060B2 (en) | 2018-02-12 | 2021-07-06 | The Regents Of The University Of Colorado, A Body Corporate | Compounds and methods for treating autoimmunity |
US11013707B2 (en) | 2018-03-23 | 2021-05-25 | The Regents Of The University Of Colorado, A Body Corporate | Administration of oral methyldopa |
CN109806237A (en) * | 2019-03-13 | 2019-05-28 | 悦康药业集团上海制药有限公司 | A kind of Ciprofloxacin Lactate effervescent tablet and preparation method thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5096714A (en) * | 1988-06-28 | 1992-03-17 | Hauser-Kuhrts, Inc. | Prolonged release drug tablet formulations |
JPH0624959A (en) * | 1991-10-04 | 1994-02-01 | Bayer Yakuhin Kk | Medice release solid pharmaceutical preparation of gastric suspending type sustained |
DE4406424A1 (en) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandable dosage forms |
DE19839057A1 (en) * | 1998-08-28 | 2000-03-02 | Koch Berthold | Purge air controller for a drying device for compressed air |
EE200100153A (en) * | 1998-09-14 | 2002-06-17 | Ranbaxy Laboratories Limited | Controlled drug delivery system for oral drug delivery that provides temporal and spatial control |
-
2001
- 2001-02-28 BR BR0108958-7A patent/BR0108958A/en not_active Withdrawn
- 2001-02-28 NZ NZ520927A patent/NZ520927A/en unknown
- 2001-02-28 AU AU35897/01A patent/AU3589701A/en not_active Abandoned
- 2001-02-28 SK SK1254-2002A patent/SK12542002A3/en unknown
- 2001-02-28 YU YU66202A patent/YU66202A/en unknown
- 2001-02-28 EA EA200200914A patent/EA200200914A1/en unknown
- 2001-02-28 CZ CZ20022883A patent/CZ20022883A3/en unknown
- 2001-02-28 OA OA1200200267A patent/OA12381A/en unknown
- 2001-02-28 EP EP01908038A patent/EP1263409A1/en not_active Withdrawn
- 2001-02-28 AP APAP/P/2002/002627A patent/AP1485A/en active
- 2001-02-28 AR ARP010100957A patent/AR032614A1/en not_active Application Discontinuation
- 2001-02-28 AP APAP/P/2001/002084A patent/AP2001002084A0/en unknown
- 2001-02-28 IL IL15155301A patent/IL151553A0/en unknown
- 2001-02-28 MX MXPA02008568A patent/MXPA02008568A/en unknown
- 2001-02-28 KR KR1020027011441A patent/KR20030009374A/en not_active Application Discontinuation
- 2001-02-28 WO PCT/IB2001/000279 patent/WO2001064183A1/en not_active Application Discontinuation
- 2001-02-28 HU HU0204417A patent/HUP0204417A3/en unknown
- 2001-02-28 CN CN01805998A patent/CN1420763A/en active Pending
- 2001-02-28 PL PL01365071A patent/PL365071A1/en not_active Application Discontinuation
- 2001-02-28 EE EEP200200497A patent/EE200200497A/en unknown
- 2001-02-28 CA CA002400950A patent/CA2400950A1/en not_active Abandoned
- 2001-02-28 JP JP2001563081A patent/JP2003525229A/en not_active Withdrawn
- 2001-03-01 EC EC2001003952A patent/ECSP013952A/en unknown
- 2001-03-01 GT GT200100033A patent/GT200100033A/en unknown
- 2001-03-01 PE PE2001000206A patent/PE20011113A1/en not_active Application Discontinuation
- 2001-03-02 DO DO2001000130A patent/DOP2001000130A/en unknown
- 2001-03-02 HN HN2001000038A patent/HN2001000038A/en unknown
-
2002
- 2002-08-23 ZA ZA200206764A patent/ZA200206764B/en unknown
- 2002-08-28 IS IS6532A patent/IS6532A/en unknown
- 2002-08-28 NO NO20024108A patent/NO20024108L/en unknown
- 2002-08-30 HR HRP20020715 patent/HRP20020715A2/en not_active Application Discontinuation
- 2002-09-02 BG BG107055A patent/BG107055A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ECSP013952A (en) | 2002-04-23 |
AP2002002627A0 (en) | 2002-09-30 |
NO20024108L (en) | 2002-10-25 |
GT200100033A (en) | 2001-10-25 |
AP2001002084A0 (en) | 2001-03-31 |
IL151553A0 (en) | 2003-04-10 |
DOP2001000130A (en) | 2004-03-31 |
CN1420763A (en) | 2003-05-28 |
AP1485A (en) | 2005-10-31 |
HUP0204417A3 (en) | 2005-03-29 |
CA2400950A1 (en) | 2001-09-07 |
BR0108958A (en) | 2003-09-30 |
AR032614A1 (en) | 2003-11-19 |
HN2001000038A (en) | 2005-03-23 |
JP2003525229A (en) | 2003-08-26 |
MXPA02008568A (en) | 2003-02-24 |
CZ20022883A3 (en) | 2003-04-16 |
KR20030009374A (en) | 2003-01-29 |
NO20024108D0 (en) | 2002-08-28 |
IS6532A (en) | 2002-08-28 |
WO2001064183A1 (en) | 2001-09-07 |
AU3589701A (en) | 2001-09-12 |
NZ520927A (en) | 2003-06-30 |
HRP20020715A2 (en) | 2004-12-31 |
EA200200914A1 (en) | 2003-02-27 |
BG107055A (en) | 2003-06-30 |
YU66202A (en) | 2005-09-19 |
SK12542002A3 (en) | 2003-05-02 |
PL365071A1 (en) | 2004-12-27 |
PE20011113A1 (en) | 2001-10-14 |
EE200200497A (en) | 2004-02-16 |
EP1263409A1 (en) | 2002-12-11 |
OA12381A (en) | 2004-09-06 |
ZA200206764B (en) | 2003-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX339071B (en) | Pregelatinized starch in a controlled release formulation. | |
HRP20030951B1 (en) | Once-a-day oxycodone formulations | |
HUP0401314A2 (en) | Breath freshening film | |
PT1401501E (en) | ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF THE ACTIVE INGREDIENT | |
HUP0002935A2 (en) | Gastroretentive controlled release microspheres for improved drug delivery | |
HUP0203028A2 (en) | Pharmaceutical formulation containing tolterodine and its use | |
HUP0203176A2 (en) | Solid, oral pharmaceutical composition containing simethicone | |
ES2157881T3 (en) | PAROXETINE METHANOSULFONATE. | |
CY1111470T1 (en) | NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A | |
EP0966966A3 (en) | Nefazodone dosage form | |
BG108516A (en) | Pharmaceutical formulation | |
HUP0204417A2 (en) | Oral ciprofloxacin-composition of controlled release | |
SE0300831D0 (en) | New formulations and use therof | |
DE50005529D1 (en) | ORAL PHARMACEUTICAL FORMS FOR ADMINISTRATING A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC | |
ATE287264T1 (en) | ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE | |
HUP0104647A2 (en) | Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient | |
MXPA03008420A (en) | Solid orally-dispersible pharmaceutical formulation. | |
ATE464878T1 (en) | PHARMACEUTICAL COMPOSITION FOR NASAL USE OF FENTANYL | |
GB2420720A (en) | Orthodontic brace | |
TW200616950A (en) | Synthesis of indole analogs of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole (yc-1) as anti-platelet agents | |
AU2001252225A1 (en) | Oral composition comprising chlorhexinine and maltitol or erythritol or a mixture thereof | |
DE60202590D1 (en) | 2H-1-BENZOPYRANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS | |
DE60320039D1 (en) | TRAMADOL FORMULATIONS WITH DELAYED RELEASE AND 24 HOUR EFFICACY | |
NZ535611A (en) | Pharmaceutical composition of a PDE4 or a PDE3/4 inhibitor and a histamine receptor antagonist | |
HUP0202324A2 (en) | Prucalopride oral solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC9A | Change of name, address |
Owner name: RANBAXY LABORATORIES LIMITED, IN Free format text: FORMER OWNER(S): RANBAXY LABORATORIES LIMITED, IN; RANBAXY LABORATORIES LIMITED, IN |
|
FH91 | Appointment of a representative |
Free format text: FORMER REPRESENTATIVE(S): DR. ASBOTH DOMOKOS, DR, ASBOTH. DR. BICZI & TARSA UEGYVEDI ES SZABADALMI IRODA, HU Representative=s name: MESTER TAMAS, SWORKS NEMZETKOEZI SZABADALMI UE, HU |
|
FH92 | Termination of representative |
Representative=s name: DR. ASBOTH DOMOKOS, DR, ASBOTH. DR. BICZI & TA, HU |